Good Life Advisors LLC Buys Shares of 125,000 Metagenomi, Inc. (NASDAQ:MGX)

Good Life Advisors LLC acquired a new stake in shares of Metagenomi, Inc. (NASDAQ:MGX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 125,000 shares of the company's stock, valued at approximately $451,000. Good Life Advisors LLC owned 0.33% of Metagenomi as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. BNP Paribas Financial Markets lifted its stake in shares of Metagenomi by 130.9% in the third quarter. BNP Paribas Financial Markets now owns 12,799 shares of the company's stock worth $28,000 after acquiring an additional 7,256 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Metagenomi in the 3rd quarter valued at approximately $33,000. Rhumbline Advisers grew its position in shares of Metagenomi by 123.3% during the fourth quarter. Rhumbline Advisers now owns 11,998 shares of the company's stock worth $43,000 after buying an additional 6,626 shares in the last quarter. SG Americas Securities LLC bought a new stake in shares of Metagenomi in the fourth quarter worth $43,000. Finally, Verition Fund Management LLC acquired a new stake in Metagenomi in the third quarter valued at $82,000.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on MGX. Chardan Capital reaffirmed a "buy" rating and set a $15.00 price target on shares of Metagenomi in a research report on Wednesday, November 20th. HC Wainwright lifted their target price on Metagenomi from $7.00 to $14.00 and gave the stock a "buy" rating in a research report on Tuesday, December 10th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $16.67.

Metagenomi Stock Performance

MGX stock traded down $0.08 during mid-day trading on Friday, reaching $2.36. The company had a trading volume of 392,715 shares, compared to its average volume of 1,334,965. The stock's 50-day simple moving average is $3.03 and its two-hundred day simple moving average is $2.66. Metagenomi, Inc. has a one year low of $1.61 and a one year high of $12.50.

Metagenomi Company Profile

Metagenomi, Inc, a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases.